Longitudinal changes of serum immunoglobulins under ocrelizumab: factors associated with hypogammaglobulinemia and infection risk in a real-world multiple sclerosis cohort

Abstract Background and Objectives Ocrelizumab (OCR) is an effective anti-CD20 therapy for relapsing-remitting and primary progressive multiple sclerosis (MS), but long-term effects on humoral immunity in real-world settings remain incompletely characterized. We investigated longitudinal changes in...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Amelie Bohn, Fiona S. Teubner, Simone C. Tauber, Anne Waschbisch
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2026-06-01
Edice:	Neurological Research and Practice
Témata:	Multiple Sclerosis B-cell depletion Immunoglobulins Hypogammaglobulinemia Infection Risk
On-line přístup:	https://doi.org/10.1186/s42466-026-00509-0
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!